Philippines: IPOPHL becomes an ISA and Philippines joins the Apostille Convention

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Philippines: IPOPHL becomes an ISA and Philippines joins the Apostille Convention

On May 20 2019, the Intellectual Property Office of the Philippines (IPOPHL) started operating as an international searching authority (ISA) and international preliminary examining authority (IPEA). It now conducts search and preliminary examination of international applications filed under the Patent Cooperation Treaty (PCT) of the World Intellectual Property Organization. To encourage Filipino inventors, as well as higher educational institutions that are members of the Innovation and Technology Support Offices Network (ITSO), the IPOPHL has launched a programme waiving search and preliminary examination fees for the first 100 applicants which choose IPOPHL as the ISA or IPEA. Under this PCT Filing Assistance Program, foreign applicants from states included in WIPO's list of eligible nationals or residents may also avail of a 90% reduction of certain PCT fees. This programme is in effect until December 31 2019, or after 100 requests for ISRs have been filed, whichever comes first. The IPOPHL's Schedule of Fees as ISA can be found in the PCT Applicant's Guide – International Phase on the WIPO website. The Applicant's Guide also provides a few guidelines in relation to the IPOPHL's function as ISA, such as the conditions for refund and amount of refund of the search fee, whether the IPOPHL requires that nucleotide and/or amino acid sequence listings be furnished in electronic form, and which subject matter will not be searched, among others.

Accession to the Apostille Convention

On May 14 2019, the Philippines' accession to the Apostille Convention took effect, where foreign public documents from Apostille-contracting countries (except for Austria, Finland, Germany and Greece), once Apostillised, need not be authenticated by Philippine embassies and consulate generals in order to be recognised and accepted in the Philippines. This significantly reduces the inconvenience, time and expense in the authentication of documents. Conversely, Philippine public documents need not undergo diplomatic or consular authentication for the same to be accepted in fellow Apostille-contracting countries. The previous process of authentication by the Philippine consulate offices shall continue to apply to countries and territories which are not Apostille-contracting parties.

hechanova.jpg
barredo.jpg

Editha R Hechanova

Chrissie Ann L Barredo


Hechanova & Co., Inc.Salustiana D. Ty Tower104 Paseo de Roxas AvenueMakati City 1229, PhilippinesTel: (63) 2 812-6561Fax: (63) 2 888-4290editharh@hechanova.com.ph 

www.hechanova.com.ph

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article